A detailed history of Bayesian Capital Management, LP transactions in Certara, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 22,159 shares of CERT stock, worth $237,322. This represents 0.03% of its overall portfolio holdings.

Number of Shares
22,159
Holding current value
$237,322
% of portfolio
0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.46 - $16.58 $231,783 - $367,396
22,159 New
22,159 $259,000
Q2 2023

Aug 14, 2023

BUY
$16.89 - $24.64 $1,689 - $2,464
100 Added 0.73%
13,800 $251,000
Q1 2023

May 15, 2023

SELL
$15.9 - $24.72 $69,960 - $108,768
-4,400 Reduced 24.31%
13,700 $330,000
Q4 2022

Feb 14, 2023

BUY
$10.7 - $17.84 $193,670 - $322,904
18,100 New
18,100 $290,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.71B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.